These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 10525616)

  • 1. [p53 mutations/p53 protein overexpression. Differential significance for the progression of head-neck carcinomas].
    Bosch FX; Homann N; Conradt C; Dietz A; Erber R
    HNO; 1999 Sep; 47(9):833-48. PubMed ID: 10525616
    [No Abstract]   [Full Text] [Related]  

  • 2. [Investigations to the influence of tumor supressor gene p16 inactivation on the prognosis of head and neck squamous cell carcinoma].
    Koscielny S; V Eggeling F; Dahse R
    Laryngorhinootologie; 2004 Jun; 83(6):374-80. PubMed ID: 15197677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Examinations on the importance of the inactivation of the tumor suppressor gene p16, reactivation of the telomerase and mutation of p53 in the pathogenesis of head and neck tumors].
    Koscielny S
    Laryngorhinootologie; 2003 Mar; 82(3):197-8. PubMed ID: 12673521
    [No Abstract]   [Full Text] [Related]  

  • 4. [Prognostic factors in head-neck carcinomas].
    Weber A; Tannapfel A
    HNO; 2002 Jan; 50(1):35-42. PubMed ID: 11963785
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Overexpression of p53 as prognosis factor in vulvar carcinoma].
    Kohlberger P; Breitenecker G; Gitsch G; Sliutz G; Kölbl H; Tschachler E; Reinthaller A; Kainz C
    Gynakol Geburtshilfliche Rundsch; 1996; 36(1):40-1. PubMed ID: 8737523
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Improved prognostic assessment of head-neck carcinomas by new genetic markers].
    Bockmühl U; Küchler I; Petersen I
    HNO; 2000 Jun; 48(6):451-6. PubMed ID: 10929226
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of glutathione s-transferase and cytochrome p450 polymorphisms on prognosis of head and neck cancer].
    Matthias C; Jahnke V; Fryer AA; Strange RC
    Laryngorhinootologie; 2002 Jun; 81(6):406-12. PubMed ID: 12063626
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Translational research in head and neck cancer. Biological characteristics and general aspects].
    Dietz A; Wichmann G
    HNO; 2011 Sep; 59(9):874-84. PubMed ID: 21861150
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of epidermal growth factor receptor (EGFR) exon 20 single nucleotide polymorphism in Chinese squamous cell carcinoma of head and neck (SCCHN).
    Jin T; Yu CX; Jin T; Yu CX; Lei DP; Liu DY; Xu FL; Lu YT; Pan XL
    Acta Otolaryngol; 2009 Nov; 129(11):1306-12. PubMed ID: 19863329
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunohistochemical determination of cell cycle regulatory proteins. No prognostic significance in advanced squamous epithelial carcinomas of the head-neck area].
    Kunz C; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
    HNO; 2003 Oct; 51(10):800-5. PubMed ID: 14523533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Prognostic significance of expression of p53, bcl-2 and bax in squamous epithelial carcinoma of the larynx--a multivariate analysis].
    Jäckel MC; Sellmann L; Youssef S; Dorudian MA; Füzesi L
    HNO; 2001 Mar; 49(3):204-11. PubMed ID: 11320623
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
    Gandour-Edwards R; Trock BJ; Gumerlock P; Donald PJ
    Otolaryngol Head Neck Surg; 1998 May; 118(5):610-5. PubMed ID: 9591858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognostic significance of cell-cycle regulatory proteins for outcome after primary radiochemotherapy in patients with advanced head and neck cancer].
    Haas S; Bosch FX; Klein-Kühne W; Nollert J; Rudat V; Conradt C; Dietz A
    HNO; 1999 Sep; 47(9):777-86. PubMed ID: 10525606
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of CXCL12 and CXCR4 in inoperable head and neck squamous cell carcinoma.
    Rave-Fränk M; Tehrany N; Kitz J; Leu M; Weber HE; Burfeind P; Schliephake H; Canis M; Beissbarth T; Reichardt HM; Wolff HA
    Strahlenther Onkol; 2016 Jan; 192(1):47-54. PubMed ID: 26374452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of MAGEA2 in head and neck cancer.
    Glazer CA; Smith IM; Bhan S; Sun W; Chang SS; Pattani KM; Westra W; Khan Z; Califano JA
    Arch Otolaryngol Head Neck Surg; 2011 Mar; 137(3):286-93. PubMed ID: 21422315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Expression of tumor suppressor gene p53 and Rb in patients with epidermoid carcinoma of the head and neck].
    Schipper JH; Kelker W
    HNO; 1994 May; 42(5):270-4. PubMed ID: 8050915
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Gene therapy for head and neck cancer.
    Gleich LL
    Laryngoscope; 2000 May; 110(5 Pt 1):708-26. PubMed ID: 10807351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Expression and localization profile of tenascin in squamous cell carcinomas of the head and neck].
    Herold-Mende C; Andl T; Laemmler F; Reisser C; Eichhorn S
    HNO; 1999 Aug; 47(8):723-9. PubMed ID: 10506500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Which is the single most important factor in deciding the management and determining the prognosis of head and neck cancer?
    Ferlito A; Takes RP; Rinaldo A; Devaney KO
    Eur Arch Otorhinolaryngol; 2010 Mar; 267(3):325-6. PubMed ID: 19823861
    [No Abstract]   [Full Text] [Related]  

  • 20. [Promising approaches of translational research in head and neck cancer].
    Dietz A
    HNO; 2011 Sep; 59(9):857-8. PubMed ID: 21892801
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.